Striverdi Respimat Treats Airflow Obstructions In Patients With COPD


Striverdi Respimat is a prescription medication
used for the maintenance treatment of airflow obstruction in patients with chronic obstructive
pulmonary disease (COPD). Striverdi Respimat belongs to a group of drugs called long-acting
beta2-adrenergic agonists. These work by relaxing the airways. This medication is available as a spray for
inhalation and is taken once daily. Common side effects of Striverdi Respimat
include upper respiratory tract infections, inflammation of the nasal passages and throat,
bronchitis, urinary tract infections, cough, rash, diarrhea, back pain, and joint pain. Striverdi Respimat can also cause dizziness.
Do not drive or operate heavy machinery until you know how this medication affects you.